Bezerra, Patrícia H. A.; Amaral, Cristina; Almeida, Cristina F.; Correia-da-Silva, Georgina; Torqueti, Maria Regina 
; Teixeira, Natércia
Source: Molecules. Unidade: FCFRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, FARMACOTERAPIA, ANTIOXIDANTES, NITRILAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BEZERRA, Patrícia H. A. et al. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment. Molecules, v. 28, n. 13, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3390/molecules28134893. Acesso em: 27 jan. 2026.APA
Bezerra, P. H. A., Amaral, C., Almeida, C. F., Correia-da-Silva, G., Torqueti, M. R., & Teixeira, N. (2023). In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment. Molecules, 28( 13), 1-14. doi:10.3390/molecules28134893NLM
Bezerra PHA, Amaral C, Almeida CF, Correia-da-Silva G, Torqueti MR, Teixeira N. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment [Internet]. Molecules. 2023 ; 28( 13): 1-14.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3390/molecules28134893Vancouver
Bezerra PHA, Amaral C, Almeida CF, Correia-da-Silva G, Torqueti MR, Teixeira N. In vitro effects of combining genistein with aromatase inhibitors: concerns regarding its consumption during breast cancer treatment [Internet]. Molecules. 2023 ; 28( 13): 1-14.[citado 2026 jan. 27 ] Available from: https://doi.org/10.3390/molecules28134893
